LIFE SCIENCES SOFTWARE DEVELOPMENT
Life sciences software that passes audit, not just QA
Modus Create delivers custom life sciences software development for pharma, biotech, CRO, and MedTech teams who can't trade compliance for speed. From clinical platforms to commercial and R&D tools, we design, build, and scale software that passes audit and ships on schedule. One accountable partner, from first concept to enterprise rollout.
WHY IT MATTERS
Why software development in life sciences is different
Building software in life sciences carries constraints most development teams never face. A missed validation step isn't a bug ticket. It's a failed audit, a delayed submission, or a patient safety issue. GxP, FDA 21 CFR Part 11, its EU counterpart Annex 11, and HIPAA shape architecture decisions long before software reaches production.
Generic engineering teams treat compliance as a final layer, expensive to retrofit and rarely solid enough to hold up under audit. We treat validation, traceability, and audit readiness as design inputs, built in from the first architecture decision rather than bolted on before launch.
OUR SOLUTIONS
Our life sciences software development services
We design, build, and scale software for pharma, biotech, CRO, and MedTech teams, under the compliance constraints these environments demand.
Scoping the regulatory context, the user need, and the technical path before any build begins, so software is designed for validation from day one.
Interfaces clinical, commercial, and research teams will actually use. Usability without trading away compliance, including the engagement design that drives measurable outcomes.
Patient-facing, clinical, and research applications built from scratch. Hybrid mobile, web, and cloud-native architectures engineered to handle sensitive health data.
Security built into every layer, from access controls to deployment pipelines, aligned with the standards auditors check. Protection for sensitive health data that holds up under review rather than added as a final pass.
Predictive and generative capabilities built into the product, with the governance, validation, and audit trails regulated environments require.
Architecting software to support growth in concurrent users, data volume, and new capabilities, without compromising performance or compliance.
OUR METHODOLOGY
How Modus Create delivers life sciences software development
Every engagement starts with your regulatory context, not a generic discovery sprint. We follow a structured approach that keeps compliance and delivery aligned at each phase.
Before writing code, we establish which standards apply (GxP, Part 11, HIPAA, GDPR, sector-specific rules), where your data lives, and what validation each component will require. You leave this phase with a roadmap your clinical, regulatory, and technical stakeholders can all sign off on.
We architect systems so that traceability, access controls, and audit logging are structural. Validation documentation is produced alongside the build, which means your audit trail exists when you need it instead of being reconstructed under pressure.
We deliver working software incrementally, validating each release with real users before moving forward. Your teams stay aligned, submission timelines stay protected, and no phase locks you into a decision you can't reverse.
Security is a design input. From dependency management to deployment pipelines, we align the build with the standards your auditors will check, so reviews become routine rather than disruptive.
We document what we build, train the engineers who'll own the system, and stay available for the questions that surface after go-live. New software compounds in value only when your team can keep evolving it.
Ready to build? Let's talk about where to start.
Whether you're scoping a new clinical platform or rethinking an aging commercial tool, we'll help you find the right path forward, without overcommitting before you have the full picture.
OUR WORK
Life sciences software development in practice
We've built and modernized software for life sciences companies where downtime, compliance, and data sensitivity aren't negotiable.
A life sciences company lifts patient quit rates by 34% and builds an AI platform for clinical insight
A global life sciences company had a smoking cessation app that wasn't driving engagement, split across separate Android and iOS builds, with no reliable way to turn patient data into clinical insight. Modus Create consolidated it into a single cross-platform app on Ionic and built a cloud-native biomarker discovery engine on AWS.
- 34% improvement in patient quit success rates
- 2.5 million behavioral data points analyzed
- 85% accuracy in cessation outcome prediction
EVERSANA automates MLR review with an AI-powered platform
Modus Create built an AI platform that flags risky claims, matches them to approved evidence, and streamlines approvals with clear audit trails.
- 90% MLR automation achieved
- Faster time-to-market for commercial content
- Higher review accuracy
WHY MODUS CREATE
The life sciences software development company enterprises choose for regulated work
Building business-critical software in life sciences is a question of judgment and accountability as much as engineering. Here's what you get with us.
AWS Advanced Tier Partner with Life Sciences Competency
AWS has independently validated our technical proficiency and regulatory alignment for life sciences work. We've earned it on real compliant cloud projects for pharma, biotech, and clinical research teams.
Full-stack capability, one accountable partner
Strategy, product engineering, cloud, data, security, and AI readiness, all in-house. No subcontractors, no handoffs, no finger-pointing when something breaks.
A team that builds, not just advises
We're engineers and architects first. Our consultants write code, ship production systems, and contribute to the open source tools the industry relies on.
OUR EXPERTS
Meet the team behind your build
The engineers and architects who lead our life sciences work. They've shipped regulated software in production, not just advised on it, and they're the people you'll work with directly.
Matthew Kelch
Director, Engineering
Modus Create
Matthew is Director, Engineering at Modus Create with 15+ years of experience in full-stack product development. A remote work advocate, Matthew helps enterprises of all sizes modernize their software development practices.
LET'S GET STARTED
Talk to Modus Create
Big challenges need bold partners. Let’s talk about where you want to go — and start building the path to get there.
OUR INDUSTRY RESOURCES
Insights on software development and innovation in life sciences
Explore our latest thinking on scaling AI, modernizing platforms, and navigating regulatory complexity in life sciences.
Frequently asked questions
What is life sciences software development?
Life sciences software development is the design, engineering, and delivery of software for pharma, biotech, CRO, and MedTech organizations. It covers clinical platforms, medical affairs tools, data and evidence systems, and connected device software, each built to meet regulatory standards like GxP, FDA 21 CFR Part 11, its EU counterpart Annex 11, and HIPAA.
Why is it different from building standard software?
Life sciences software development carries one constraint standard projects don't: regulation shapes the architecture. The software must be validated, traceable, and audit-ready, with documentation produced alongside the build rather than after it. Validation, access controls, and audit logging are structural requirements, not features added late.
The specifics show up early in design decisions. Electronic signatures under 21 CFR Part 11 have to be bound to the exact record version they approved, tamper-evident, and impossible to reuse or reassign. Audit logs need append-only storage so entries can't be altered or deleted after the fact. Choices like these are difficult to retrofit, which is why they belong in the initial architecture rather than a later compliance pass.
Which regulations come into play?
Life sciences software is governed by several frameworks depending on the product and market. The most common are GxP, FDA 21 CFR Part 11 for electronic records and signatures, and its EU counterpart EU GMP Annex 11 for computerised systems. Add HIPAA for protected health information in the US, GDPR for personal data in the EU, and, for clinical trial software, the EU Clinical Trials Regulation (536/2014) under EMA oversight. Which ones apply depends on your product, your market, and the data it handles.
How long does a typical project run?
Timelines for a life sciences software project depend on scope, regulatory requirements, and integration complexity. We work in structured, shippable phases, so you see working software and measurable progress early instead of waiting for one large release at the end.
What drives the cost of a life sciences software project?
The cost of a life sciences software development project depends less on lines of code than on regulatory weight. Three factors move the budget most: the scope of validation each component requires, the complexity of integrating with existing clinical or commercial systems, and the depth of audit documentation your regulatory context demands. A patient-facing app handling protected health data carries a different validation burden than an internal analytics tool. We scope that burden upfront, so the estimate reflects the real compliance work rather than a generic development rate.
What separates a specialist partner from a generalist agency?
A specialist life sciences software partner treats compliance as a design input and brings direct experience with validation, audit, and regulated data. That means fewer costly retrofits, documentation that holds up under audit, and architecture decisions informed by what regulators actually check.